1.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: UMCT-1380
|
|
2.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PHARMACIA-088050, NCI-V96-0828
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 0 to 21 Sponsor: NCI Protocol IDs: POG-9404
|
|
4.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 21 and under Sponsor: NCI Protocol IDs: POG-9426, CCG-P9426, NCT00002827
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 21 and under Sponsor: NCI Protocol IDs: COG-9425, NCT00005578, POG-9425
|
|
6.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 1 to 17 Sponsor: NCI Protocol IDs: DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
|
|
7.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 30 and under Sponsor: NCI Protocol IDs: COG-P9754, POG-P9754, COG-P9754, CCG-P9754, NCT00003937, P9754
|
|
8.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 25 and under at diagnosis Sponsor: NCI Protocol IDs: NCI-00-C-0092G, AMGEN-20000124, NCT00020137
|
|
9.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-49808, NCT00016276, CALGB-49808
|
|
10.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NYU-8305, NCI-T83-1038D, T83-1038
|
|
11.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: DUT-BR-1, NCI-T85-0009Q, T85-0009
|
|
12.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: AECM-8710267, NCI-V88-0363
|
|
13.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: GUMC-20989, NCI-V89-0278
|
|
14.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: YALE-HIC-4660, NCI-V88-0378
|
|
15.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 25 and under Sponsor: NCI Protocol IDs: NCI-89-C-07, NCI-T88-0200N, T88-0200
|
|
16.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: TCSC-ADR-529/LUNG, NCI-V89-0172
|
|
17.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: TCSC-ADR-529/BREAST, NCI-V89-0171
|
|
18.
|
Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: any age Sponsor: NCI Protocol IDs: CLB-9631, CALGB-9631
|
|
19.
|
Phase: Phase II Type: Treatment Status: Completed Age: 3 to 60 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-98074, ENDOREX-MSKCC-98074, MDA-ID-97198, NCI-G98-1487, NCT00003667
|
|
20.
|
Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 25 and under Sponsor: NCI Protocol IDs: NCI-99-C-0125I, NCT00019864
|
|
21.
|
Phase: Phase II Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: WSU-C-36480
|
|
22.
|
Phase: Phase II Type: Treatment Status: Closed Age: under 72 Sponsor: Protocol IDs: UMCT-1680, UMCT-1680A
|
|
23.
|
Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-4282
|
|
24.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: SEG-LUN-82264, SEG-LUN-82-264
|
|
25.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: SEG-HN-82280, SEG-HN-82-280
|